These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31027754)

  • 1. A versatile HPLC method with an isocratic single mobile phase system for simultaneous determination of anti-glaucoma formulations containing timolol.
    Ibrahim FA; Elmansi HM; El Abass SA
    Ann Pharm Fr; 2019 Jul; 77(4):302-312. PubMed ID: 31027754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid and sensitive HPLC method for the simultaneous determination of dorzolamide hydrochloride and timolol maleate in eye drops with diode-array and UV detection.
    Erk N
    Pharmazie; 2003 Jul; 58(7):491-3. PubMed ID: 12889534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validated HPLC-DAD Method for the Simultaneous Determination of Six Selected Drugs Used in the Treatment of Glaucoma.
    Baker MM; Belal TS
    J AOAC Int; 2018 Jul; 101(4):993-1000. PubMed ID: 28859698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous determination of dorzolamide HCL and timolol maleate in eye drops by two different spectroscopic methods.
    Erk N
    J Pharm Biomed Anal; 2002 Apr; 28(2):391-7. PubMed ID: 11929684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous determination of timolol maleate in combination with some other anti-glaucoma drugs in rabbit aqueous humor by high performance liquid chromatography-tandem mass spectroscopy.
    Hassib ST; Elkady EF; Sayed RM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jun; 1022():109-117. PubMed ID: 27085020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous determination of dorzolomide and timolol in aqueous humor: a novel salting out liquid-liquid microextraction combined with HPLC.
    Mohamed AM; Abdel-Wadood HM; Mousa HS
    Talanta; 2014 Dec; 130():495-505. PubMed ID: 25159439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel and rapid validated stability-indicating UPLC method of related substances for dorzolamide hydrochloride and timolol maleate in ophthalmic dosage form.
    Sharma N; Rao SS; Reddy AM
    J Chromatogr Sci; 2012 Oct; 50(9):745-55. PubMed ID: 22562819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
    Reis R; Queiroz CF; Santos LC; Avila MP; Magacho L
    Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A European perspective on costs and cost effectiveness of ophthalmic combinations in the treatment of open-angle glaucoma.
    Hommer A; Thygesen J; Ferreras A; Wickstrom J; Friis MM; Buchholz P; Walt JG
    Eur J Ophthalmol; 2008; 18(5):778-86. PubMed ID: 18850558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the ocular hypotensive effect of brimonidine, dorzolamide, latanoprost, or artificial tears added to timolol in glaucomatous monkey eyes.
    Wang RF; Serle JB; Gagliuso DJ; Podos SM
    J Glaucoma; 2000 Dec; 9(6):458-62. PubMed ID: 11131752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
    Michaud JE; Friren B;
    Am J Ophthalmol; 2001 Aug; 132(2):235-43. PubMed ID: 11476685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular comfort of combination glaucoma therapies: brimonidine 0.2%/timolol 0.5% compared with dorzolamide 2%/timolol 0.5%.
    Chan K; Testa M; McCluskey P
    J Ocul Pharmacol Ther; 2007 Aug; 23(4):372-6. PubMed ID: 17803436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of dorzolamide/timolol vs brinzolamide/brimonidine fixed combination therapy in the management of primary open-angle glaucoma.
    Kozobolis V; Panos GD; Konstantinidis A; Labiris G
    Eur J Ophthalmol; 2017 Mar; 27(2):160-163. PubMed ID: 27445072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fixed-combination brimonidine/timolol as adjunctive therapy to a prostaglandin analog: a 3-month, open-label, replacement study in glaucoma patients.
    Nguyen QH; Earl M
    J Ocul Pharmacol Ther; 2009 Dec; 25(6):541-4. PubMed ID: 20028261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A one-week comfort study of BID-dosed brinzolamide 1%/timolol 0.5% ophthalmic suspension fixed combination compared to BID-dosed dorzolamide 2%/timolol 0.5% ophthalmic solution in patients with open-angle glaucoma or ocular hypertension.
    Vold SD; Evans RM; Stewart RH; Walters T; Mallick S
    J Ocul Pharmacol Ther; 2008 Dec; 24(6):601-5. PubMed ID: 19049301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A New UPLC Method with Chemometric Design-Optimization Approach for the Simultaneous Quantitation of Brimonidine Tartrate and Timolol Maleate in an Eye Drop Preparation.
    Büker E; Dinç E
    J Chromatogr Sci; 2017 Feb; 55(2):154-161. PubMed ID: 27881494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An eight-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure.
    Hatanaka M; Grigera DE; Barbosa WL; Jordao M; Susanna R
    J Glaucoma; 2008 Dec; 17(8):674-9. PubMed ID: 19092465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo corneal effects of latanoprost combined with brimonidine, timolol, dorzolamide, or brinzolamide.
    Fukuda M; Takeda N; Shibata S; Shibata N; Shibata T; Sugiyama K; Sasaki H
    Eur J Pharmacol; 2016 Sep; 787():43-6. PubMed ID: 27181069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dorzolamide/timolol combination versus concomitant administration of brimonidine and timolol: six-month comparison of efficacy and tolerability.
    Sall KN; Greff LJ; Johnson-Pratt LR; DeLucca PT; Polis AB; Kolodny AH; Fletcher CA; Cassel DA; Boyle DR; Skobieranda F
    Ophthalmology; 2003 Mar; 110(3):615-24. PubMed ID: 12623832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-month, randomized, parallel-group comparison of brimonidine-timolol versus dorzolamide-timolol fixed-combination therapy.
    Nixon DR; Yan DB; Chartrand JP; Piemontesi RL; Simonyi S; Hollander DA
    Curr Med Res Opin; 2009 Jul; 25(7):1645-53. PubMed ID: 19476406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.